Enabling CROs, pharma, healthcare and lifesciences industries with disruptive e-signature and smart document solutions
Srini Dokka, Global Sales Head, MSB Docs, explains the role of digital signatures that is giving an edge in this patient care, sustainability and profitability war to numerous health entities
Digital transformation has been one of the key methodologies leveraged by health leaders during COVID times. The sector, due to its criticality perforce, maintains a paper chain of approvals, certifications, permissions, tests, prescriptions and patient histories that is unfathomable in scale. The negative carbon impact and lower profitability are seen as a necessary cost of delivering excellence in patient care.
Smart document digital transformation is giving an edge in this patient care, sustainability and profitability war to numerous health entities – including eight out of the leading 10 pharma organisations globally, such as Pfizer, Roche and more. In the case of the UK-based biopharma organisation, its clinical research associates now spend more time on their experiments and less time chasing paper. This has helped them in the process of developing and commercialising new therapies for oncology and rare diseases.
Organisations in the business of health-allied industries across the board have leveraged smart digital document transformation to create hereto unheard-of efficiencies and positive outcomes. Looking at different industry streams, the benefits can be classified as:
Digitisation with speed, life-saving and cost-saving benefits:
- The healthcare industry is improving its capacity planning and patient registration, patient consent, lab operations, reports creation, routing and storage, discharge summary and billing, insurance claim processing, appointment bookings, prescription management and pharmacy operations, amongst many other functions.
- The pharma industry has streamlined and speeded up the process of patient contracts, patient consent forms, patient assistance documents, vendor contracts, sales agreements, electronic batch records, Key Opinion Leader (KOL) programmes, clinical trial onboarding and many others.
- The lifesciences industry has seen gains across clinical trials, lab accreditation, new drug discovery, engagement of lab professionals, audit trail, feedback and training, inspection reports and others.
Protecting sensitive data benefits essential in the heightened legal and social scrutiny environment of today:
- The digitisation of paper documents has helped in enforcing access authentication to sensitive/critical data that was earlier under the risk of lock and key anonymity.
- Regular risk assessment is now conducted to ensure continuity of data safety.
- Data en